Stay updated on Nivolumab vs Temozolomide in GBM Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Temozolomide in GBM Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A banner announces an NIH-wide transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The site revision updates from v3.7.1 to v3.7.2; the study record remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T21:57:38.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T21:57:17.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the usual study record content, and the previous study details and navigation are removed, leaving a generic error page with the footer.
    Difference
    18%
    Check dated 2026-09-22T23:00:58.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    A new page revision label, Revision: v3.7.0, was added. The previous revision label, Revision: v3.6.6, was removed, indicating an update to the page.
    Difference
    0.0%
    Check dated 2026-09-15T20:37:35.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6. This indicates a small backend/template update and does not alter the study information shown.
    Difference
    0.0%
    Check dated 2026-09-01T19:30:33.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    A new entry indicating an NIH grant/contract in 2015 was added to the study record. This adds funding attribution alongside existing identifiers without altering the substantive information of the study.
    Difference
    0.0%
    Check dated 2026-08-25T20:47:13.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Temozolomide in GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.